KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cvs Health (CVS) Income from Continuing Operations (2016 - 2025)

Cvs Health's Income from Continuing Operations history spans 17 years, with the latest figure at 2923000000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 80.1% year-over-year to 2923000000.0, compared with a TTM value of 1728000000.0 through Dec 2025, down 62.32%, and an annual FY2025 reading of 1728000000.0, down 62.32% over the prior year.
  • Income from Continuing Operations for Q4 2025 was 2923000000.0 at Cvs Health, up from 3990000000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 3039000000.0 in Q2 2022, with the low at 3990000000.0 in Q3 2025.
  • Average Income from Continuing Operations over 5 years is 1349900000.0, with a median of 1848000000.0 recorded in 2023.
  • Year-over-year, Income from Continuing Operations skyrocketed 166.64% in 2023 and then crashed 5719.72% in 2025.
  • Tracing CVS's Income from Continuing Operations over 5 years: stood at 1387000000.0 in 2021, then skyrocketed by 68.13% to 2332000000.0 in 2022, then fell by 12.22% to 2047000000.0 in 2023, then decreased by 20.71% to 1623000000.0 in 2024, then soared by 80.1% to 2923000000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVS's Income from Continuing Operations are 2923000000.0 (Q4 2025), 3990000000.0 (Q3 2025), and 1013000000.0 (Q2 2025).